Differences in pathology, staging, and treatment between HIV+ and uninfected patients with microscopically confirmed hepatocellular carcinoma
Cancer Epidemiology, Biomarkers & Prevention Nov 26, 2019
Torgersen J, Taddei TH, Park LS, et al. - Given a substantially higher incidence of hepatocellular carcinoma (HCC) among HIV-infected (HIV+) than uninfected persons, researchers sought to examine if, in the setting of HIV infection, HCC is morphologically distinct or more aggressive. From the Veterans Aging Cohort Study, they identified 873 patients with HCC (399 HIV+) from 2000 to 2015; of these, 140 HIV+ and 178 uninfected persons had undergone liver tissue sampling and had microscopically confirmed HCC. They identified no differences in HCC tumor characteristics or background hepatic parenchyma by HIV status, yet an association of HIV with poorer survival was observed. Of note, pathology reports frequently omitted these characteristics.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries